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The incidence of obesity and metabolic disease,
such as type 2 diabetes mellitus (T2D), is rising
globally. Dietary lipid over supply leads to lipid
accumulation at ectopic sites, such as skeletal
muscle. Ectopic lipid storage is highly correlated
with insulin resistance and T2D, likely due to a
loss of metabolic flexibility – the capacity to switch
between fat and glucose oxidation upon insulin
stimulation – and cellular dysfunction because of
lipotoxicity. However, muscle lipid levels are also
elevated in endurance-trained athletes, presenting
a paradoxical phenotype of increased intramuscu-
lar lipids along with high insulin sensitivity – the
‘athletes’ paradox’. This review focuses on recent
human data to characterize intramuscular lipid
species in order to elucidate some of the
underlying mechanisms driving skeletal muscle
lipotoxicity. There is evidence that lipotoxicity is
characterized by an increase in bioactive lipid
species, such as ceramide. The athletes’ paradox
supports the notion that regular physical exercise
has health benefits that might originate from the
alleviation of lipotoxicity. Indeed, exercise training
alleviates intramuscular ceramide content in obese
individuals without a necessary decrease in ecto-
pic lipid storage. Furthermore, evidence shows
that exercise training elevates markers of lipid
droplet dynamics such as the PLIN proteins, and
triglyceride lipases ATGL and HSL, as well as
mitochondrial efficiency, potentially explaining
the improved lipid turnover and a reduction in
the accumulation of lipotoxic intermediates
observed with the athelets’ paradox.
Keywords: athletes’ paradox, exercise, lipotoxicity,
obesity, skeletal muscle, type 2 diabetes mellitus
(T2D).
Introduction
Global levels of individuals’ body weights are rising
at epidemic proportions. The World Health Orga-
nization (WHO) reported a doubling in world obe-
sity levels in 2016 since 1980 [1]. In 2016, 39% of
adults were overweight (BMI ≥ 25), and 13% of
adults were obese (BMI ≥ 30) [1]. The fundamental
cause of excessive weight is an imbalance between
energy consumption and energy expenditure.
Overweight and obesity are risk factors for meta-
bolic diseases including insulin resistance (IR) and
type 2 diabetes mellitus (T2D), heart disease and
various cancers. Although the underlying biologi-
cal mechanisms that link obesity to metabolic
disease are not completely understood, it is
obvious that the flexibility in substrate utilization
for energy provision becomes progressively
impaired in overweight and obese individuals.
Metabolic flexibility is the degree to which meta-
bolic tissues, such as muscle, liver and the heart,
can switch between substrates for essential ATP
production based on acute changes to nutrient
availability and energy demands. Impaired meta-
bolic flexibility is highly correlated with insulin
resistance [2] and interventions that result in
improved metabolic flexibility also tend to alleviate
insulin resistance and vice versa. During fasting
conditions, such as between meals, plasma insulin
levels are low, and therefore, tissue glucose oxida-
tion is low. Under these conditions, most energy is
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derived from the oxidation of fatty acids. Thus,
plasma glucose levels can be maintained and serve
to fuel several organs and tissues, such as the
brain that mainly relies on glucose as a source for
energy production. In the fasted condition, adipose
tissue lipolysis is stimulated, liberating free fatty
acids into the blood stream as a consequence. The
free fatty acids are taken up by metabolic tissues
and utilized for energy production via fat oxidation.
On the other hand, following a mixed meal there is a
surgeinplasmaglucosefollowedbyareleaseofinsulin
into the plasma. Insulin-sensitive tissues respond to
the insulin by taking up glucose from the circulation.
The glucose taken up by these tissues is either stored
within the tissues or oxidized to produce ATP. When
tissues become insulin resistant a state of metabolic
inflexibility occurs resulting in a reduced clearance of
glucose from the circulationpostprandially. Indeed, it
has been shown that obese and T2D patients have a
markedly reduced metabolic flexibility, which could
be largely attributed to a reducedmetabolic flexibility
at the level of the skeletal muscle [3]. Therefore,
understanding the link between overweight or obesity
and metabolic inflexibility may be important in the
development of strategies to fight metabolic diseases.
Lipotoxicity isbelievedtobeacontributor tometabolic
inflexibility. Lipotoxicity is defined as cellular dys-
function resulting from the excessive and ectopic
accumulation of lipids in the cell.
One of the best strategies to improve metabolic
flexibility is via exercise training. People partici-
pating in habitual exercise training are typically of
good metabolic health, with high metabolic flexi-
bility. Understanding how adaptations to exercise
training lead to improved management of lipids
and prevention of lipotoxicity may allow the iden-
tification of novel therapeutic targets for the treat-
ment of insulin resistance.
Ectopic fat accumulation
In humans, by far, the largest fat storage site is within
white adipocytes. A white adipocyte, from now on
referred to as adipocyte, is composed of a large lipid
droplet, occupying approximately 90% of the cellular
space [4, 5]. The remaining cellular space is occupied
by a nucleus and other organelles, including mito-
chondria. Adipose tissue not only stores fatty acids as
triacylglycerol, but also possesses endocrine func-
tions,withtheability toproduceandreleasecytokines
(adipokines) including leptin, adiponectin, resistin,
acylation stimulating protein, tumor necrosis factor-
a, plasminogen activator inhibitor-1 and interleukin-
6 [6]. In general, adipokines are proposed to play two
main roles, one being to direct whole-body metabo-
lism and the other in inflammatory processes that
may occur in the obese state when adipose tissue
function is impaired.
Lipids are important in many biological processes
such as facilitating hormone synthesis and synthe-
sis of phospholipids that make up cellular mem-
branes. Adipose tissue stores triacylglycerol to fuel
metabolic processes upon demand. The latter is the
primary reason for lipidstorage inadipocytes, that is
to provide energy to other tissues when needed.
Following lipolysis nonesterified fatty acids (NEFA)
are released from adipocytes into circulation and
takenup by other tissues including skeletalmuscle,
liver, heart, kidney and pancreas. In these tissues,
lipids are primarily utilized for energy production;
however, there is also the capacity for lipid storageat
these ectopic sites, probably for the short-term
buffering of excessive fat coming into the system.
In the healthy state, this so-called ectopic fat accu-
mulation is, under most conditions, rather low,
except for the skeletal muscle where the storage of
lipids within the muscle cells serves as a readily
available substrate source for the mitochondria
upon muscle contraction/physical activity. Partic-
ularly, long-term endurance exercise activities are
characterized by a reliance on the use of intramus-
cular triglyceride stores for energy production.
Obesity is the result of over nutrition that leads to a
net-positive energy balance. When there is a pos-
itive energy balance fat storage increases within
adipocytes resulting in either hypertrophy, hyper-
plasia or both [7]. Although the human body has a
large capacity for the storage of fat in adipose
tissue, ectopic lipid storage is especially prevalent
in overweight and obese people, and is believed to
be the result of the limited expandability and
proliferation of adipocytes [8]. Hence, fatty acids
spill over from the adipose tissue into the circula-
tion to be taken up by peripheral tissues. Espe-
cially in these ectopic fat stores, fat storage may
lead to lipotoxicity. Indeed, hepatic, cardiac and
muscular steatosis are linked to diseases such
fatty liver disease, steatohepatitis, cirrhosis, heart
disease, heart failure, IR and T2D [9–11].
The athletes’ paradox
Skeletal muscle from highly trained athletes is
characterized with high levels of ectopic fat
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storage in muscle – intramuscular lipid (IMCL)
droplets – at a comparable level to individuals
with T2D [12]. Moderate-to-high intensity exercise
gives rise to a high energy demand at the
exercising muscle, and the IMCL may benefit
the exercising tissue by supplying free fatty acids
at the site of the energy demand [13, 14]. The
combined presence of high levels of IMCL along
with a high insulin sensitivity is referred to as the
‘athletes’ paradox’. According to the lipotoxicity
theory, IMCLs are associated with metabolic
complications. However, athletes presenting with
increased IMCL do not possess these same
metabolic issues and in fact have improved
insulin sensitivity when compared to individuals
with insulin resistance and similar IMCL levels,
and lean, sedentary people with lower levels of
IMCL [12, 15].
In recent years, efforts have been made to unpack
the contradictory health outcomes associated with
IMCL. In these attempts, the leading hypothesis
has been that IMCL per se is not lipotoxic, but that
IMCL is a marker for the accumulation of other
bioactive fatty acid intermediates within ectopic fat
stores, such as within skeletal muscle. Thus,
several studies have examined diacylglyceride
(DAG) and ceramide levels, intermediates of fatty
acid metabolism, in subjects with varying meta-
bolic health statuses, including endurance-trained
athletes [15–24]. The published data from these
studies, however, are not conclusive. While one
study reports significantly lower intramuscular
saturated DAG levels in athletes compared to a
lean sedentary group [15] another reported
increased levels of DAG, including saturated
DAGs, in their athlete cohort [16]. Intramuscular
DAGs have also been reported to be lower in obese
subjects compared to lean controls [20, 24]. Incon-
sistencies are also found for the level of ceramides
in skeletal muscle, albeit to a lesser extent. Thus,
intramuscular ceramides were reported to be
higher in several obese cohorts compared to a
lean, sedentary group [16, 21–24] and an athlete
group [20]. Bergman et al. [17], however, found no
difference in muscle ceramides in obese subjects
compared to athletes. The link between intramus-
cular ceramides and insulin resistance may be
more robust as elevated intramuscular ceramide
levels have been reported in patients with T2D [17]
and people at risk of developing T2D [19, 22],
whereas no such reports with direct data on DAG
levels in T2D patients have been made. Notably,
the saturated C:18 ceramide species is repeatedly
found to be elevated in the muscle from IR and T2D
patients [17, 19, 22]. Thus, the athletes’ paradox
may involve a role for specific fatty acid interme-
diates; however, the concept is not completely
unravelled and is more complex than initially
thought. The initial and pioneering studies either
used histological approaches using lipid soluble
dyes that stain any type of neutral lipids [12, 16,
25–27] or took advantage of noninvasive 1H-NMR
spectroscopy to quantify the CH2 peaks in the
1H
spectra, predominantly reflecting fatty acid acyl
chains [28–30]. None of these methods measures
the so-called bioactive lipids like DAG or cera-
mides. To measure bioactive lipids, more advanced
mass spectrometry on lipids extracted from the
host tissue is warranted. However, upon extracting
the lipids important information on the cellular
location of these bioactive lipids is lost. Another
complicating issue, when it comes to DAG analy-
sis, is the subcellular origin of the respective
optical isomers of DAG. Incomplete hydrolysis of
TAG in lipid droplets (LD) will result in elevated
DAG levels. Importantly, though, ATGL-mediated
hydrolysis of TAGs in LDs results in sn-2,3 DAG or
sn-1,3 DAG [31], whereas the DAG subtype with
recognized insulin desensitizing properties is sn-
1,2 DAG [32, 33], originating from phospholipid
synthesis. For complete comprehension of the
complex relationship between lipid moieties and
insulin resistance, novel technology like in situ
application of imaging mass spectrometry can be
very helpful [34]. The role of fatty acid intermedi-
ates in insulin resistance has been reviewed
extensively elsewhere [35].
As an alternative explanation for the athletes’
paradox, it has been proposed that the turnover
of lipid stores inside the skeletal muscle is a key
determinant of lipotoxicity. As such, the nature of
lipid storage and breakdown-related enzymes,
mitochondrial characteristics and LD characteris-
tics has been the focus of much investigation in
order to elucidate the mechanism of lipotoxicity. It
has been reported that there is no difference in the
intramuscular expression of TAG/DAG biosynthe-
sis-related proteins glycerol-3-phosphate acyl-
transferase (GPAT), phosphatidate phosphatase
(PAP-1) and DAG acyltransferase (DGAT) between
healthy, lean and insulin resistant, obese subjects
[24]. There is also no difference in ceramide/
sphingosine synthesis proteins stearoyl-CoA desat-
urase-1 (SCD-1), serine palmitoyltransferase (SPT),
ceramide synthase, sphingomyelinase and cerami-
dase.
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Protein phosphatase 2A (PP2A) is upregulated in
skeletal muscle of obese subjects concomitant with
elevated ceramide levels. PP2A is a direct target of
ceramide [36], and its activation by ceramide
results in a downregulation of the insulin sig-
nalling pathway [37]. While the hydrolysis of TAGs
by adipose triglyceride lipase (ATGL) appears to be
normal in skeletal muscle of obese individuals,
DAG hydrolysis is reduced, possibly due to a
reduction in hormone-sensitive lipase (HSL) [20],
providing a mechanistic explanation as to how
myocellular DAG levels can be elevated. In line, it
was also found that HSL content in muscle is
reduced in T2D subjects [20]. The rate-limiting
step of fatty acid oxidation is at the level of
mitochondrial entry, a process facilitated by the
enzyme carnitine palmitoyl transferase (CPT).
Interestingly, skeletal muscle CPT activity is
reduced in obese individuals compared to lean
individuals [38]. Thus, lipid breakdown activity in
muscle is reduced in obesity and T2D, and there is
also reduced lipid input into the mitochondria; two
potential mechanistic explanations for the appar-
ent metabolic inflexibility.
In more recent years, research has focused on the
way lipids are stored at ectopic sites, such as
skeletal muscle. Thus, fatty acids are stored in
small lipid droplets that are surrounded by a
package of lipid droplet coating proteins. Lipid
droplet characteristics, such as size, proximity to
mitochondria and expression of proteins involved
in the regulation of LD lipolysis, may therefore play
a role in governing the efficiency of LD turnover in
ectopic lipid sites. The perilipin (PLIN) protein
family is one of the most abundant protein families
located on LDs. PLIN2, PLIN3 and PLIN5 are
muscle expressed PLINs and the most studied in
terms of their role in promoting LD hydrolysis in
skeletal muscle. PLIN2 and PLIN3 are considered
important for the formation of LDs [39, 40] and
PLIN3 for budding off of nascent LDs from the
endoplasmic reticulum. PLIN5, on the other hand,
regulates lipolysis and also associates LDs to the
mitochondria [41, 42]. In human muscle, PLIN5
has been shown to be highly associated with ATGL
(94  10%) [43]. Work from our laboratory shows
that PLIN5 protein is more abundant in muscle
from trained individuals compared to lean seden-
tary, obese and T2D patients [44] suggesting an
important role in diminishing lipotoxic effects of
muscle lipids. Athletes also present with a higher
number of LDs. LD number and PLIN5-associated
LDs correlate positively with VO2max, a marker for
muscle oxidative capacity [44]. Figure 1 is a series
of immunofluorescent images from our laboratory
showing the differences in LD dynamics between
athletes and patients with T2D.
Table 1 summarizes the data on IMCL, LD charac-
teristics and lipid processing markers. In general,
differences in health statuses (sedentary, trained,
obese and T2D) present with different intramus-
cular lipid signatures concomitant with differences
in regulators of lipid storage and utilization; overall
in more healthy conditions, lipid droplet dynamics
(storage and release of fatty acids from the
droplets) and the protein machinery needed for
this tend to be better matched towards oxidative
needs. However, deciphering how lipid droplet
dynamics is involved in disease development and
progression remains a major challenge.
A role for oxidative capacity in explaining the athletes’ paradox
A striking difference between athletes and obese
and insulin-resistant subjects, who are character-
ized by similar levels of IMCL, is the oxidative
capacity of the muscle. Thus, we and others have
shown that T2D patients are characterized by a
reduced mitochondrial function [45–48]. One of the
hypotheses to explain the athletes’ paradox there-
fore is that not the level of intramuscular lipids per
se, but their turnover is important. Obviously, one
of the determinants of a high lipid droplet turnover
is having a high oxidative capacity. Thus, a high
oxidative capacity can be hypothesized to prevent
lipid-induced lipotoxicity. To test this hypothesis,
acute lipid and hyperinsulin infusion studies, a
model that mimics the circulating factors of obe-
sity, IR and T2D and induces IR [49, 50], have been
used to elucidate the fate of lipids and metabolic
effects. Data from our laboratory show that acute
lipid infusion combined with hyperinsulinemia
leads to IR in young endurance trained and lean
sedentary subjects [51] even within 3 h. In the
trained group, however, the IR was only ~29% and
was accounted for by a reduction in insulin-
stimulated glucose oxidation, whereas in the
untrained subjects, both insulin-stimulated glu-
cose oxidation and nonoxidative glucose disposal
(glycogen storage) were impeded, leading to an
overall 70% decrease in insulin sensitivity. We have
also reported impaired oxidative and nonoxidative
glucose disposal in subjects with T2D in associa-
tion with increased circulating NEFA levels [45].
Another study reported similar outcomes when
studying an obese, lean sedentary and trained
Exercise and lipotoxicity / E. Zacharewicz et al.
508 ª 2018 The Association for the Publication of the Journal of Internal Medicine
Journal of Internal Medicine, 2018, 284; 505–518
group [52]. All three subject groups developed IR
upon lipid infusion, but the obese group had a
greater degree of IR compared to the other two
groups. While glucose oxidation did not change,
nonoxidative glucose disposal was reduced in the
sedentary and obese group but increased in the
athletes. Possibly reflective of good metabolic flex-
ibility, the lipid infusion did not increase IMCL
levels in the athletes, whereas in the sedentary
subjects, IMCL levels were increased [51].
Although it is tempting to speculate that this
higher fat oxidative capacity prevents the accu-
mulation of lipid intermediates, levels of specific
lipid species have unfortunately not been
reported in most of these studies. One study did
report on specific IMCL species and found that
lipid infusion specifically increased intramuscular
DAGs in lean, sedentary but not trained athletes
[53].
As another model to elevate plasma NEFA levels,
we employed a 60-h fasting protocol to induce
insulin resistance [54]. Upon fasting, IMCL levels
were also increased with a specific increase in the
number and size of PLIN5-associated LDs. PLIN5-
positive LD size negatively correlated with fasting-
induced reduction in ADP-driven state-3 respira-
tion and maximal uncoupled respiration [54].
Taken together, this suggests that PLIN5 protects
the muscle from fasting-induced reduction in
(a) (b) (c)
(d) (e) (f)
Fig. 1 Cross-sectional immunofluorescent image of a human m. vastus lateralis section of a type I muscle fibre from a
trained athlete (a, b. c) and a patient with T2D (d, e, f). Lipid droplets are stained in green, the lipid droplet coat protein PLIN5
is stained in red, and the basement membrane protein laminin is stained in blue. These images exemplify a few of the
characteristic differences related to lipotoxicity and fat storage between insulin-sensitive trained individuals and insulin-
resistant sedentary individuals. In the trained state, the fat is stored in more lipid droplets that are smaller (panel a). A large
proportion of lipid droplets are associated with PLIN5 (yellow, panel b) and not membrane associated (panel c). Individuals
with T2D present with fewer but larger lipid droplets (panel d). More cytosolic PLIN5 is observed with less association with
lipid droplets (panel e). A greater number of lipid droplets are found within the vicinity of the cellular membrane (panel f).
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Table 1 Human studies investigating intramuscular lipid storage and intramuscular lipid storage regulators and markers of
mitochondrial function. Studies were included on the basis that they investigated intramuscular lipid storage and/or
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mitochondrial function possibly through main-
tained flux of fatty acid oxidation.
Effects of acute and chronic exercise on lipotoxicity
Having a good understanding of the differences in
lipid content characteristics between athletes and
type 2 diabetes patients, what can be referred to as
two extremes at the spectrum of metabolic health,
provides valuable information regarding the under-
lying molecular mechanisms of lipotoxicity. How-
ever, whilst generating such data may be helpful
for the identification of therapeutic targets, it is
also important to realize that exercise per se is one
of the best strategies to treat and prevent T2D.
Therefore, it is also important to understand the
effects of acute exercise bouts and long-term exer-
cise programmes on endogenous lipids and the
progression of metabolic disease.
Acute exercise is known to transiently increase the
capacity for glucose uptake in skeletal muscle,
amongst others via the activation of AMPK. Inter-
estingly, acute exercise may also have effects on
several intramuscular lipid species. We and others
have shown an acute bout of exercise reduces
IMCL content in healthy individuals [30, 55–57].
This reduction can be accounted for by a reduction
in LD density and size [56]. Specifically, from pre-
to postexercise, there is a significant reduction in
size for PLIN2-associated LDs and no change in
PLIN2-negative LDs. This suggests that there is
preferential oxidation of PLIN2-associated lipids
with acute exercise. Another study reports no
change in PLIN5-associated LD before and after
an acute exercise bout [43]. However, IMCL was not
reduced with the exercise bout, potentially due to
insufficient exercise intensity or duration or a
combination of both for the recreationally active
cohort that was used. Few studies have investi-
gated the effect of acute exercise on IMCL in insulin
resistant or T2D patients. One hour of endurance
training per day reduces IMCL content after 3 days
in T2D, healthy sedentary and trained individuals
[58]. On the other hand, lipid intermediates,
ceramide and dihydroceramides, are increased
immediately after exercise in patients with T2D,
obese participants and endurance-trained ath-
letes. Thus, in this postexercise period that is
characterized by elevated glucose uptake, bioactive
insulin desensitizing lipids appear elevated. Dur-
ing recovery, however, total ceramides and several
long-chain saturated ceramide species are signifi-
cantly reduced compared to baseline in the T2D
cohort [17]. Sphingosine and sphingosine-1-phos-
phate followed a similar pattern, with an increase
immediately postexercise and return to baseline
during recovery in all the subjects. Understanding
how these acute changes affect metabolic health
outcomes is one of the upcoming challenges we are
facing.
While acute exercise has the potential to reduce
muscle lipid content, chronic exercise training
augments muscle lipid storage. However, endur-
ance-trained athletes and obese insulin-resistant
volunteers vary in many long-term metabolic adap-
tations, and examining the effect of chronic exer-
cise training in populations prone to developing
diabetes may reveal more interesting information
regarding the role of lipotoxicity in the development
of insulin resistance. PLIN2, PLIN3 and PLIN5
protein expressions are higher in trained subjects
compared to sedentary subjects [59, 60], and
PLIN5 expression is also higher in trained com-
pared to obese[16] and trained compared to T2D
[44]. Endurance exercise training increases ATGL
protein expression and HSL activation, by phos-
phorylation, concomitant with a reduction in IMCL
in both lean [61] and obese subjects [62]. It is
hypothesized that also with chronic exercise train-
ing the reduction in TAG intermediates, such as
DAGs and ceramides, may explain the beneficial
effects of exercise training, such as improvement in
insulin sensitivity [63, 64]. Indeed, a 16-week
aerobic training programme in older, overweight
and obese subjects resulted in an improvement in
insulin sensitivity concomitant with an increase in
IMCL but with significant reductions in muscle
DAG and ceramides [25]. Succinate dehydrogenase
(SDH), a marker for oxidative capacity, and glyco-
gen content were both increased following the
training protocol. This indicates that mitochondrial
function and nonoxidative glucose disposal were
both improved in this subject cohort. Eight weeks
of exercise training in obese individuals also
resulted in a reduction in IMCL content [62], more
specifically in a reduction in ceramides and a
nearly significant reduction in total DAGs [65].
While the role of intramuscular lipid species in the
muscle is not completely known, current literature
certainly points to elevated ceramide as the more
notorious player in metabolic disease. Of note, the
C18:0 ceramide species that is elevated in IR and
T2D patients [17, 19, 22] is reduced 2 h after an
acute exercise bout [17] but also after at least
4 weeks of training in obese subjects [63, 65]. This
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Table 2 Human studies investigating intramuscular lipid storage and intramuscular lipid storage regulators and markers of
mitochondrial function following exercise intervention. Studies were included on the basis that they investigated
intramuscular lipid storage and/or intramuscular lipid storage regulators. ↑ indicates increased expression; ↓ indicates
decreased expression; ? indicates no change
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is in line with another study in obese individuals
showing that – although IMCL levels were unal-
tered after 4 weeks of training – insulin sensitivity
was improved along with a reduction in intramy-
ocellular ceramides [63]. Interestingly, ceramide
levels correlated negatively with PLIN expression
[63] suggesting that the expression of PLINs is
important for the promotion of neutral lipid storage
rather than bioactive lipid intermediates.
In obese subjects, 4 weeks of exercise training also
results in increased PLIN2, PLIN3 and PLIN5
expression and increased mitochondrial size and
number [63]. Interestingly, mitochondrial size has
been positively correlated with insulin sensitivity
[66]. As a result of the increase in mitochondrial
size, an increase in LDs associated with mitochon-
dria was found, which in turn correlated positively
with PLIN levels [63]. The timing and sequence of the
respective adaptive responses of mitochondria, LDs
and their coating proteins remain to be elucidated.
In a study examining the longer term effects of
exercise training onmuscle lipidmetabolism in T2D
patients, PLIN2 muscle expression was increased
after 8 weeks of endurance training while IMCL
elevations were only observed after 24 weeks of
training [67]. However, the relationship between
muscle PLIN expression and exercise training is not
Fig. 2 Schematic representation of lipid processing within an endurance-trained muscle vs a type 2 diabetic muscle. The
endurance-trained muscle is characterized by a greater number of PLIN proteins and PLIN-associated LDs and PLIN-
associated mitochondria. Endurance training also increases HSL activity and CPT inside the mitochondria and
mitochondrial size and number. Therefore, lipid hydrolysis and oxidation are more efficient in endurance-trained muscle.
Ceramides are kept low, and insulin signalling is maintained. In T2D, there is less PLIN and LD-mitochondria association
and reduced HSL activity. Lipid hydrolysis is inefficient and lipid intermediates such as ceramides and DAGs accumulate,
inhibiting insulin signalling pathways.
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consistently reported as 8 weeks of training
increased PLIN3 and PLIN5 expression, but not
PLIN2 in obese subjects [62], although PLIN2 was
increased in T2D patients with 8-weeks of training
[67], and 12 weeks of exercise training resulted only
in increased PLIN5 in obese subjects [68]. Table 2
summarizes the effects of exercise on IMCL, LD
characteristics and lipid processing markers.
It is also interesting to note that changes in
insulin sensitivity and intramuscular lipids are
not always accompanied by weight loss or even
body fat loss [63, 65] suggesting that fat promot-
ing turnover of ectopic lipids or redistribution of
fat away from ectopic sites towards inert storage
in adipocytes is of importance in the pathogene-
sis of metabolic disease rather than loss of fat
mass per se. Exercise-induced improvements in
mitochondrial function and fat oxidative capacity
may be responsible for keeping fatty acid inter-
mediates low in skeletal muscle, suggesting that
the turnover of intramuscular triglycerides,
including their controlled release from the lipid
droplet, transport towards the mitochondria and
intramitochondrial combustion is an important
determinant of skeletal muscle lipotoxicity. Fig-
ure 2 is a schematic representation of how lipid
processing may occur in an exercise trained and
T2D muscle tissue.
Conclusion
Lipotoxicity is characterized by an increase in
ectopic lipid storage, not necessarily of triglyc-
erides, but bioactive insulin desensitizing lipid
species such as ceramides. Ceramides play a role
in suppressing insulin signalling pathways and are
thereby factors that impede insulin sensitivity.
Accumulation of muscle lipids due to lipid over
supply results in a reduction in lipid hydrolysis
efficiency. Therefore, lipotoxicity is the failure of
muscle to deal with excess lipid uptake. Acute
exercise has immediate beneficial effects such as
reducing intramuscular lipids in obese and T2D
patients, thereby stimulating lipid hydrolysis and
oxidation. However, muscle adaptations to long-
term exercise programmes are important in
improving health outcomes and reversing insulin
resistance. Exercise programmes increase muscle
PLIN and lipid hydrolysing enzymes. Furthermore,
toxic lipid species such as ceramides are reduced
upon physical exercise training, alleviating the
inhibition of insulin signalling pathways and thus
contributing to improving insulin sensitivity.
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